BioLife Solutions, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Amy DuRoss

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Amy DuRoss”): 39,902,654 for, 646,034 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,503,393 for, 30,991 withheld, 1,219 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Directors: Cathy Coste

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Catherine Coste”): 40,460,424 for, 88,264 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,535,603 for.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Directors: Joydeep Goswami

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Joydeep Goswami”): 23,021,878 for, 17,526,810 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 57% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 11,274,353 for, 9,081,312 withheld, 179,938 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Directors: Rachel Ellingson

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Rachel Ellingson”): 20,731,406 for, 19,817,282 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 51.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 8,599,530 for, 11,159,918 withheld, 776,155 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Directors: Timothy L. Moore

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Timothy Moore”): 40,089,287 for, 459,401 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,509,130 for, 26,472 withheld, 1 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Directors: Tony Hunt

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Tony Hunt”): 39,264,968 for, 1,283,720 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disq…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 20,052,407 for, 483,194 withheld, 2 abstained.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Description as filed by funds: Election of Directors: Roderick de Greef

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Roderick de Greef”): 39,608,298 for, 940,390 withheld, per its Form 8-K filed August 21, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 20,041,591 for, 483,920 withheld, 2 abstained.

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

BioLife Solutions, Inc.’s own tally for this item (“2. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers”): 38,403,856 for, 2,060,352 against — passed, per its Form 8-K filed August 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the Company's named executive officers by a non-binding, advisory vote was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 74 managers: 19,374,916 for, 1,182,286 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 207 managers: 27,532,569 for, 1,940,786 against, 152 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

BioLife Solutions, Inc.’s own tally for this item (“3. Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 43,024,019 for, 11,169 against — passed, per its Form 8-K filed August 21, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 20,557,202 for.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.